
Dysfunction of the synovial lymphatic system (SLS) has been implicated in the pathogenesis of inflammatory arthritis, including rheumatoid arthritis and post-traumatic osteoarthritis (OA), but its role in age-related OA has largely remained unexplored. Evidence now suggests that impaired SLS function contributes to the progression of age-related OA and that it could be therapeutically targeted by administration of vascular endothelial growth factor C (VEGF-C), the main growth factor for lymphatic endothelial cells.
Like
Save
Share